Oral medicines are available, and the new crown epidemic has become a daily life? ?

Canada on Monday approved Pfizer's oral Covid-19 drug to treat adults with mild to moderate Covid-19 cases. According to reports, the drug is effective in preventing severe illness and mortality by nearly 90%.

"(This approval) is particularly important because easy-to-use Covid-19 drugs may help reduce severe illness rates in adults with Covid-19," said Theresa Tam, Canada's chief public health officer.

Clinical trial data of Pfizer's antiviral drug Paxlovid show that the drug can effectively prevent the risk of hospitalization and death, with an effective rate of nearly 90% in patients with high risk of severe disease. This means that patients can take medicines at home for five days for home treatment after symptoms appear in the new crown.

The Canadian government said last month that it had signed a deal with Pfizer for a total of 1 million courses of the drug and was awaiting approval. However, due to global supply shortages, only a fraction of the medicines are able to reach Canada anytime soon.